InVita Healthcare Technologies Announces Increasing Adoption of WarrantyTracker at Healthcare Facilities Nationwide

WarrantyTracker takes explant management to the next level — expanding beyond warranty claims to support patient safety, compliance, and the full lifecycle of implanted devices, helping nearly 100 hospitals nationwide.

BALTIMORE, June 26, 2025 /PRNewswire/ — InVita Healthcare Technologies, a leading provider of specialized software solutions for Human Biologics and Health & Public Safety, today announced the growing adoption of its expanded WarrantyTracker™ software solution with more than 20 new healthcare facilities licensed in the past 24 months. Now used by nearly 100 hospitals nationwide, WarrantyTracker reduces audit risk, streamlines warranty claims, and maximizes credit recovery. Building on its core functionality, the platform has evolved into a comprehensive explant management solution, supporting the full lifecycle of implanted devices while enhancing compliance and patient safety.

WarrantyTracker expands to 100 hospitals, supporting compliance, patient safety & implanted device lifecycle management.

Hospitals have long faced challenges with fragmented, manual warranty claims processes that requires coordination across clinical, supply chain, billing, and regulatory teams. To meet the Centers for Medicare & Medicaid Services (CMS) and Office of Inspection General (OIG) requirements, hospitals must track claim status for all device types, pursue eligible warranty credits for explanted devices that carry a manufacturer’s warranty, determine which claim credits are due to CMS, and apply them accurately with proper coding for Medicare reimbursement.

Originally developed to automate this complex process, WarrantyTracker remains the only complete solution that ensures compliance with CMS and OIG guidelines across all device types—both in-process and completed. The platform supports full electronic documentation aligned with OIG and Recovery Audit Contractor (RAC) standards. Through integration with hospital EHRs and medical device manufacturers, WarrantyTracker provides daily status updates, links claims to patient records, and enables 100% electronic submissions using EHR-derived data—saving time and improving accuracy.

Now, WarrantyTracker has evolved into a comprehensive explant management solution. Its capabilities extend beyond warranty claims to support the full lifecycle of implanted devices—from product registration and complaint reporting to real-time recall visibility. Hospitals can register devices, document and report adverse events directly to manufacturers, and flag recalled devices immediately within the platform. This ensures timely investigations, complete documentation, and manufacturer follow-up, while also supporting proper warranty type selection and accurate CMS coding for billing and compliance.

“As hospitals face growing demands around compliance, recalls, and patient safety, we’re proud of WarrantyTracker’s evolution into a comprehensive explant management solution that meets those needs,” said Todd Collins, President & CEO of InVita. “From product registration to identifying a recalled device and reporting adverse events to the manufacturer, hospitals now have the tools to act quickly, stay compliant, and protect patients—without the added administrative burden.”

About InVita Healthcare Technologies

View original content to download multimedia:https://www.prnewswire.com/news-releases/invita-healthcare-technologies-announces-increasing-adoption-of-warrantytracker-at-healthcare-facilities-nationwide-302491453.html

SOURCE InVita Healthcare Technologies

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

47 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

12 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

15 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

15 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

15 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

15 hours ago